Monitoring therapy with a gonadotropin-releasing hormone analog: utility of MR imaging.
Zawin M, McCarthy S, Scoutt L, Lange R, Lavy G, Vulte J, Comite F. Monitoring therapy with a gonadotropin-releasing hormone analog: utility of MR imaging. Radiology 1990, 175: 503-6. PMID: 2109336, DOI: 10.1148/radiology.175.2.2109336.Peer-Reviewed Original ResearchMeSH KeywordsAbdominal NeoplasmsAdultAntineoplastic AgentsEndometriosisFemaleGonadotropin-Releasing HormoneHumansLeiomyomaLeuprolideMagnetic Resonance ImagingMiddle AgedUterine NeoplasmsConceptsGonadotropin-releasing hormone analoguePlacebo groupGnRH analoguesDrug groupsHormone analogueMR imagingMonths of therapyConservative therapyFibroid volumeSignificant changesUterine leiomyomaMagnetic resonanceTherapyMonthsSignificant decreaseWomenEndometriosisSignificant reductionVessel conspicuityGroupImagingEndometriomasPatientsLeiomyomaPelvis